Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2023

Interventional Procedures in High-Risk Decompensated Valvular Heart Disease

Presenter: Thomas Waggoner

October 26, 2023

Presentation TCT 2023

TCT 630: Mitral Transcatheter Edge-to-Edge Repair in Multiple Valvular Heart Disease: Outcomes With Combined Aortic Insufficiency and Mitral Regurgitation

Presenter: Ahmad Mustafa

October 25, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Daily News

Rheumatoid Arthritis and Aortic Stenosis: A Plausible Link—Now What?

Shelley Wood

August 01, 2023

Presentation SCCT 2023

Introduction to Structural Heart Disease: Non Valvular Disease

Presenter: Mohamed Marwan

July 28, 2023

Presentation SCCT 2023

Intro to Structural Heart Disease – Valvular Heart Disease

Presenter: Tiffany Chen

July 28, 2023

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

L.A. McKeown

July 27, 2023

News Conference News TVT 2023

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

Michael O'Riordan

June 13, 2023

News Conference News EHRA 2023

EPs Push for More Involvement in TAVI Heart Team Discussions

Michael O'Riordan

April 21, 2023

News Conference News THT 2023

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

Caitlin E. Cox

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

Advertisement

Interventional Procedures in High-Risk Decompensated Valvular Heart Disease

TCT 630: Mitral Transcatheter Edge-to-Edge Repair in Multiple Valvular Heart Disease: Outcomes With Combined Aortic Insufficiency and Mitral Regurgitation

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

Rheumatoid Arthritis and Aortic Stenosis: A Plausible Link—Now What?

Introduction to Structural Heart Disease: Non Valvular Disease

Intro to Structural Heart Disease – Valvular Heart Disease

Women and Minorities Underrepresented in Heart Valve Trials

Prior TAVI Patients Needing Non-Aortic Valve Surgery Face Poor Outcomes

EPs Push for More Involvement in TAVI Heart Team Discussions

Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry

TEER or VAD/Transplant in the Advanced HF Patient With MR?

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Top Structural Heart News of 2022

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content